Enhanced osteoblastic differentiation of parietal bone in a novel murine model of mucopolysaccharidosis type II
Mucopolysaccharidosis type II (MPS II, OMIM 309900) is an X-linked disorder caused by a deficiency of lysosomal enzyme iduronate-2-sulfatase (IDS). The clinical manifestations of MPS II involve cognitive decline, bone deformity, and visceral disorders. These manifestations are closely associated wit...
Main Authors: | Narutoshi Yamazaki, Mari Ohira, Shuji Takada, Akira Ohtake, Masafumi Onodera, Mahito Nakanishi, Torayuki Okuyama, Ryuichi Mashima |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Molecular Genetics and Metabolism Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426923000678 |
Similar Items
-
A 1‐year and 4‐month‐old child with mucopolysaccharidoses type II: A clinical case report from Ethiopia
by: Solomie Jebessa Deribessa, et al.
Published: (2021-11-01) -
Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan
by: Yusuke Hattori, et al.
Published: (2023-12-01) -
Functional assessment of the genetic findings indicating mucopolysaccharidosis type II in the prenatal setting
by: Maria Fuller, et al.
Published: (2021-07-01) -
Corrigendum to “Enhanced osteoblastic differentiation of parietal bone in a novel murine model of mucopolysaccharidosis type II” [Molecular Genetics and Metabolism Reports Vol. 37, December 2023, 101021]
by: Narutoshi Yamazaki, et al.
Published: (2024-12-01) -
Case report: a rare case of Hunter syndrome (type II mucopolysaccharidosis) in a girl
by: A. N. Semyachkina, et al.
Published: (2019-05-01)